Literature DB >> 1617201

Bovine spongiform encephalopathy.

R H Kimberlin1.   

Abstract

A detailed account is given of the occurrence of bovine spongiform encephalopathy (BSE), current research into the aetiology of this new disease of cattle, and the relationship between BSE, scrapie and other similar diseases. Epidemiology, clinical signs, pathology, diagnosis, prevention and control are described.

Entities:  

Mesh：

Year:  1992        PMID： 1617201     DOI： 10.20506/rst.11.2.608

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN： 0253-1933            Impact factor:   1.181


  5 in total

1.  Hydrated autoclave pretreatment enhancement of prion protein immunoreactivity in formalin-fixed bovine spongiform encephalopathy-affected brain.

Authors:  M Haritani; Y I Spencer; G A Wells
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

2.  Bovine spongiform encephalopathy identified in a cow imported to Canada from the United Kingdom--a case report.

Authors:  S S Chen; K M Charlton; A V Balachandran; B P O'Connor; C C Jenson
Journal:  Can Vet J       Date:  1996-01       Impact factor: 1.008

3.  Population-level retrospective study of neurologically expressed disorders in ruminants before the onset of bovine spongiform encephalopathy (BSE) in Belgium, a BSE risk III country.

Authors:  C Saegerman; D Berkvens; L Claes; A Dewaele; F Coignoul; R Ducatelle; D Cassart; B Brochier; F Costy; S Roels; H Deluyker; E Vanopdenbosch; E Thiry
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

4.  Decision support tools for clinical diagnosis of disease in cows with suspected bovine spongiform encephalopathy.

Authors:  C Saegerman; N Speybroeck; S Roels; E Vanopdenbosch; E Thiry; D Berkvens
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

Review 5.  Evaluating ultraviolet sensitivity of adventitious agents in biopharmaceutical manufacturing.

Authors:  Sarah M Meunier; Michael R Sasges; Marc G Aucoin
Journal:  J Ind Microbiol Biotechnol       Date:  2017-03-10       Impact factor: 3.346
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.